Describing what they do as Non-invasive Liver Disease Diagnostics, Livivos is has developed LiverScope® -- a Point-of-Care liver disease diagnostic device that has the potential radically to change how fatty liver and other chronic liver diseases are detected, graded, and managed. Teamed with the Liver Imaging Group at University of California San Diego (UC San Diego) under the direction of Dr. Claude Sirlin, Professor of Radiology in the School of Medicine, the effort si to evaluate the LiverScope® devices ability to measure quantitative biomarkers of fatty liver disease, a condition with steadily increasing global prevalence that has been linked to cardiovascular disease and diabetes and can progress to more serious liver disorders. The firm is working to obtain FDA clearance such that their LiverScope® project would be available to patients across the US, with a long-term goal of placing it in clinical environments world-wi
